Steven Cohen Novo Cure LTD Put Options Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $604,350 - $1.24 Million	15,000 New	15,000 $622,000
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $8.75 Million - $18.4 Million	-155,000 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $9.92 Million - $13.2 Million	155,000 New	155,000 $11.4 Million

265

76.5M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.57B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.